Bringing the innovative cell and gene therapies to market is a journey unlike any other, with changing expectations along the way. We understand the challenges in bringing cell and gene therapies to market.
For patients, they represent the promise of curative treatment. Healthcare professionals are excited by their potential but daunted by the upheaval of long-established practices. And for payors, they demand entirely new
models of assessing value that need to be established.
We specifically established our GenERA offering to partner with cell and gene therapies companies, is your experienced navigator to achieving success in this journey.
We have supported products across vector and delivery modalities, and understand the science.
